MW
BMY icon

Marble Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Marble Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Buy
5,356
+317
+6% +$18.2K 0.05% 191
2026
Q1 		$306K Sell
5,039
-3,528
-41% -$206K 0.05% 179
2025
Q4 		$462K Buy
+8,567
New +$412K 0.06% 175

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marble Wealth's BMY Position: Q2 2026 in Review

Marble Wealth increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q2 2026, buying an estimated $18.2K and bringing the position to 5,356 shares worth $309K. The position accounts for 0.05% of the portfolio, ranked #191.

Marble Wealth first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $462K in Q4 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Marble Wealth held 5,356 shares of Bristol-Myers Squibb worth $309K as of Q2 2026.
  • Marble Wealth bought 317 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.2K.
  • Bristol-Myers Squibb made up 0.05% of Marble Wealth's portfolio in Q2 2026, its #191 holding.
  • Marble Wealth first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Marble Wealth's Bristol-Myers Squibb position peaked at $462K in Q4 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Marble Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.